Last updated 2026-06-18
- Acquired by Generex Biotechnology Corporation, Oct 2015
Total raised
—
Stage
Acquired
Founded
2007
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
MediTemp has developed a cooling device designed to improve sperm quality in men who are infertile due to varicoceles. The company's first product is Varicure, a compact and portable device thatfacilitates localized cooling of the testicular area with the aim to obviate male infertility due to poor semen quality. Varicure offers a conservative, safe, economic, and effective first-line therapy option to restore male fertility.
Q&A
- What is Meditemp's primary product?
- Meditemp's primary product is Varicure, a compact and portable cooling device designed to improve sperm quality in men infertile due to varicoceles.
- When was Meditemp acquired and by whom?
- Meditemp was acquired by Generex Biotechnology Corporation in October 2015.
- What is Meditemp's current operational status?
- Meditemp is currently inactive due to its acquisition by Generex Biotechnology Corporation in October 2015.
- Where is Meditemp's headquarters located?
- Meditemp's headquarters is in Haifa, Israel.
- What sector does Meditemp operate in?
- Meditemp operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- Does Meditemp hold any patents?
- Yes, Meditemp holds one patent.
- Who is the CEO of Meditemp?
- Jacob Dagan is the CEO of Meditemp.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
non-invasivemedical-devicestreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2007-1 |
|---|---|
| Employees (exact) | 6 |
| Offices | Oakland |
| Status reason | Acquired (Inactive) by Generex Biotechnology Corporation on Oct 2015 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Generex Biotechnology Corporation 2015-10
Radar intelligence
Patents
| EPO | 2 |
|---|